关于BAG5通过使用综合性多omics方法促进非小细胞肺癌的机制性见解
Jing-Shan Huang1,2,3, Jia-Mei Wang4, Ye Yuan2
1Department of Thoracic Surgery, the Shengjing Hospital, China Medical University, Shenyang, China.
Frontiers in immunology
|August 11, 2025
概括
BAG5是非小细胞肺癌 (NSCLC) 的关键蛋白质,调节RNA代谢,线粒体功能和细胞入侵. 针对BAG5可能为NSCLC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 包括BAG5在内的Bcl-2关联的乙原体 (BAG) 家族是参与癌症相关的细胞过程的共同参与者.
- BAG5在非小细胞肺癌 (NSCLC) 中的特定作用尚不清楚.
- 多学科数据集成是理解复杂生物机制的日益增长的领域.
研究的目的:
- 综合研究BAG5在NSCLC中的功能,采用多组学方法.
- 探索BAG5在NSCLC中调节的分子通路.
- 评估BAG5作为NSCLC治疗点的潜力.
主要方法:
- 单细胞转录组学,蛋白质组学,相互作用组学和光蛋白质组学数据的综合分析.
- 使用NSCLC细胞系和患者衍生器官 (PDO) 的功能验证.
主要成果:
- BAG5显著调节RNA代谢,线粒体动力学和NSCLC中的代谢重编程.
- BAG5涉及细胞骨重塑和上皮细胞转移 (EMT),促进NSCLC的扩散和入侵.
- BAG5影响了NSCLC进展关键的多个分子通路.
结论:
- BAG5通过多种分子机制在NSCLC中发挥着关键的致癌作用.
- 向BAG5为NSCLC治疗提供了一个潜在的新疗法策略.
关键词:
BAG5 BAG5 BAG5 BAG5 BAG5 BAG5 BAG5 BAG5 BAG5 BAG5 BAG5 BAG5 BAG5 BAG5在EMT中,EMT是EMT.在NSCLCLC中,我们可以看到.代谢重编程是指代谢重编程.多种主题的多种主题.更多相关视频
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
01:22PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K